{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T23:44:08Z","timestamp":1693698248152},"reference-count":93,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngologic Clinics of North America"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.otc.2012.05.002","type":"journal-article","created":{"date-parts":[[2012,7,12]],"date-time":"2012-07-12T01:45:43Z","timestamp":1342057543000},"page":"899-917","source":"Crossref","is-referenced-by-count":5,"title":["Economic Impact of Human Papillomavirus\u2013Associated Head and Neck Cancers in the United States"],"prefix":"10.1016","volume":"45","author":[{"given":"Diarmuid","family":"Coughlan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin D.","family":"Frick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.otc.2012.05.002_bib1","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.22963","article-title":"Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?","volume":"110","author":"Sturgis","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.otc.2012.05.002_bib2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/ijc.24339","article-title":"Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma?","volume":"125","author":"N\u00e4sman","year":"2009","journal-title":"Int J Cancer"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.otc.2012.05.002_bib4","doi-asserted-by":"crossref","first-page":"665","DOI":"10.6004\/jnccn.2011.0055","article-title":"The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms?","volume":"9","author":"Sturgis","year":"2011","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"32","key":"10.1016\/j.otc.2012.05.002_bib5","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.otc.2012.05.002_bib6","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1086\/597755","article-title":"Oral sexual behaviors associated with prevalent oral human papillomavirus infection","volume":"199","author":"D\u2019Souza","year":"2009","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.otc.2012.05.002_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11912-010-0084-5","article-title":"Human papillomavirus: changing paradigms in oropharyngeal cancer","volume":"12","author":"Adelstein","year":"2010","journal-title":"Curr Oncol Rep"},{"issue":"6","key":"10.1016\/j.otc.2012.05.002_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.seminoncol.2004.09.011","article-title":"Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity","volume":"31","author":"Gillison","year":"2004","journal-title":"Semin Oncol"},{"issue":"9","key":"10.1016\/j.otc.2012.05.002_bib9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1086\/597756","article-title":"Oral sexual behaviors and the prevalence of oral human papillomavirus infection","volume":"199","author":"Kreimer","year":"2009","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.otc.2012.05.002_bib10","unstructured":"Landro L. Throat cancer linked to virus [Internet]. wsjcom. 2011. Available at: http:\/\/online.wsj.com\/article\/SB10001424052702303657404576355403363380510.html. Accessed June 11, 2012."},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/bjo.2005.084848","article-title":"The calculation and use of economic burden data","volume":"90","author":"Frick","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.otc.2012.05.002_bib12","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.oraloncology.2010.08.011","article-title":"Oropharyngeal squamous cell carcinoma: a unique disease on the rise?","volume":"46","author":"van Monsjou","year":"2010","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","article-title":"Cost-of-illness studies: a guide to critical evaluation","volume":"29","author":"Larg","year":"2011","journal-title":"Pharmacoeconomics"},{"issue":"7 Suppl 1","key":"10.1016\/j.otc.2012.05.002_bib14","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/MLR.0b013e3181a23e12","article-title":"Challenges in building disease-based national health accounts","volume":"47","author":"Rosen","year":"2009","journal-title":"Med Care"},{"issue":"1","key":"10.1016\/j.otc.2012.05.002_bib15","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1524-4733.2007.00210.x","article-title":"Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost","volume":"11","author":"Clabaugh","year":"2008","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.otc.2012.05.002_bib16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MOO.0b013e328017f669","article-title":"The economics of squamous cell carcinoma of the head and neck","volume":"15","author":"Menzin","year":"2007","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.otc.2012.05.002_bib17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10198-003-0204-3","article-title":"Economic burden of head and neck cancer. A literature review","volume":"5","author":"Lee","year":"2004","journal-title":"Eur J Health Econ"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib18","first-page":"759","article-title":"Economic assessments of head and neck cancers: a review","volume":"88","author":"Selke","year":"2001","journal-title":"Bull Cancer"},{"issue":"5","key":"10.1016\/j.otc.2012.05.002_bib19","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajog.2008.03.064","article-title":"The economic burden of noncervical human papillomavirus disease in the United States","volume":"198","author":"Hu","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"Suppl 10","key":"10.1016\/j.otc.2012.05.002_bib20","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1002\/cncr.23761","article-title":"Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003","volume":"113","author":"Ekwueme","year":"2008","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.otc.2012.05.002_bib21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1001\/archotol.130.11.1269","article-title":"The economic cost of squamous cell cancer of the head and neck: findings from linked SEER-Medicare data","volume":"130","author":"Lang","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.otc.2012.05.002_bib22","first-page":"421","article-title":"Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population","volume":"14","author":"Amonkar","year":"2011","journal-title":"J\u00a0Med Econ"},{"issue":"11","key":"10.1016\/j.otc.2012.05.002_bib23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hed.21269","article-title":"Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C","volume":"31","author":"Adelstein","year":"2009","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib24","doi-asserted-by":"crossref","first-page":"A172","DOI":"10.1016\/j.jval.2011.02.955","article-title":"Health care resource utilization and economic burden of metastatic and recurrent locally-advanced head and neck cancer patients","volume":"14","author":"Le","year":"2011","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib25","doi-asserted-by":"crossref","first-page":"A47","DOI":"10.1016\/S1098-3015(10)73299-X","article-title":"First year cost expenditures associated with head and neck cancer diagnosis in the U.S. managed care population","volume":"12","author":"Choi","year":"2009","journal-title":"Value Health"},{"issue":"2","key":"10.1016\/j.otc.2012.05.002_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/hed.20670","article-title":"Cost of care for early- and late-stage oral and pharyngeal cancer in the California Medicaid population","volume":"30","author":"Epstein","year":"2008","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib27","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/cncr.25721","article-title":"Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States","volume":"117","author":"Wong","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.otc.2012.05.002_bib28","unstructured":"NCCN clinical practice guidelines in oncology [Internet]. Available at: http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp. Accessed July 22, 2011."},{"issue":"2","key":"10.1016\/j.otc.2012.05.002_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bjoms.2011.02.002","article-title":"Survey of the use of tests for human papilloma virus and epidermal growth factor receptor for squamous cell carcinoma of the head and neck in UK head and neck multidisciplinary teams","volume":"50","author":"Ahmed","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.otc.2012.05.002_bib30","series-title":"Therapeutic and diagnostic device outcomes research","author":"Ackerman","year":"2011"},{"key":"10.1016\/j.otc.2012.05.002_bib31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3109\/00365513.2010.493411","article-title":"When do new biomarkers make economic sense?","volume":"242","author":"Scott","year":"2010","journal-title":"Scand J Clin Lab Invest Suppl"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib32","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/lary.20533","article-title":"Prognostic significance of human papillomavirus in oropharyngeal squamous cell carcinomas","volume":"119","author":"Sedaghat","year":"2009","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.otc.2012.05.002_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.otc.2012.05.002_bib34","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1200\/JCO.2004.00.3335","article-title":"Molecular classification identifies a subset of human papillomavirus\u2013associated oropharyngeal cancers with favorable prognosis","volume":"24","author":"Weinberger","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"36","key":"10.1016\/j.otc.2012.05.002_bib35","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2005.04.6136","article-title":"High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma","volume":"24","author":"Licitra","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib36","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/ijc.22355","article-title":"Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer","volume":"120","author":"Reimers","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.otc.2012.05.002_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2011.02.002","article-title":"Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know","volume":"304","author":"Tribius","year":"2011","journal-title":"Cancer Lett"},{"issue":"10","key":"10.1016\/j.otc.2012.05.002_bib38","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.oraloncology.2010.07.006","article-title":"Human papilloma virus in locally advanced stage III\/IV squamous cell cancer of the oropharynx and impact on choice of therapy","volume":"46","author":"Ihloff","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.otc.2012.05.002_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006205.pub2","article-title":"Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment","volume":"4","author":"Oliver","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.otc.2012.05.002_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006386.pub3","article-title":"Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy","volume":"4","author":"Furness","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.otc.2012.05.002_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006387.pub2","article-title":"Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy","volume":"12","author":"Glenny","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.otc.2012.05.002_bib42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/lary.21456","article-title":"Impact of surgeon and hospital volume on short-term outcomes and cost of oropharyngeal cancer surgical care","volume":"121","author":"Gourin","year":"2011","journal-title":"Laryngoscope"},{"issue":"7","key":"10.1016\/j.otc.2012.05.002_bib43","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1097\/01.prs.0000260591.82762.b5","article-title":"Postoperative medical complications\u2013not microsurgical complications\u2013negatively influence the morbidity, mortality, and true costs after microsurgical reconstruction for head and neck cancer","volume":"119","author":"Jones","year":"2007","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"10.1016\/j.otc.2012.05.002_bib44","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/archoto.2010.184","article-title":"To TORS or not to TORS: but is that the question?: comment on \u201ctransoral robotic surgery for advanced oropharyngeal carcinoma\u201d","volume":"136","author":"Garden","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.otc.2012.05.002_bib45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1758-3284-1-36","article-title":"HPV & head and neck cancer: a descriptive update","volume":"1","author":"Goon","year":"2009","journal-title":"Head Neck Oncol"},{"issue":"5","key":"10.1016\/j.otc.2012.05.002_bib46","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1586\/erp.10.51","article-title":"Cost\u2013effectiveness studies in radiation therapy","volume":"10","author":"Sher","year":"2010","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.otc.2012.05.002_bib47","series-title":"Methods for the economic evaluation of health care programmes","author":"Drummond","year":"2005"},{"issue":"1","key":"10.1016\/j.otc.2012.05.002_bib48","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2007.04.002","article-title":"Evidence-based radiation oncology in head and neck squamous cell carcinoma","volume":"85","author":"Corv\u00f2","year":"2007","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.otc.2012.05.002_bib49","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1158\/1055-9965.EPI-10-1262","article-title":"Relationship between epidermal growth factor receptor status, p16(INK4A), and outcome in head and neck squamous cell carcinoma","volume":"20","author":"Young","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.otc.2012.05.002_bib50","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/archoto.2009.46","article-title":"Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck","volume":"135","author":"Lang","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"4","key":"10.1016\/j.otc.2012.05.002_bib51","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ijrobp.2007.01.053","article-title":"Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies","volume":"68","author":"Elting","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.otc.2012.05.002_bib52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.jncimonographs.a003440","article-title":"Mucositis in head and neck cancer: economic and quality-of-life outcomes","volume":"29","author":"Peterman","year":"2001","journal-title":"J\u00a0Natl Cancer Inst Monographs"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib53","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/014556130108000818","article-title":"Cost-effectiveness of two types of dysphagia care in head and neck cancer: a preliminary report","volume":"80","author":"Aviv","year":"2001","journal-title":"Ear Nose Throat J"},{"issue":"9","key":"10.1016\/j.otc.2012.05.002_bib54","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hed.20045","article-title":"Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management","volume":"26","author":"Chambers","year":"2004","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib55","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ijc.22851","article-title":"Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis","volume":"121","author":"Ragin","year":"2007","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.otc.2012.05.002_bib56","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archotol.1984.00800350006003","article-title":"Changing patterns of failure in advanced head and neck cancer","volume":"110","author":"Vikram","year":"1984","journal-title":"Arch Otolaryngol"},{"issue":"6","key":"10.1016\/j.otc.2012.05.002_bib57","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1200\/JCO.2010.31.8311","article-title":"Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer","volume":"29","author":"Morris","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.otc.2012.05.002_bib58","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s00405-010-1377-x","article-title":"Head and neck squamous cell cancers: need for an organised time-bound surveillance plan","volume":"267","author":"Kazi","year":"2010","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"6","key":"10.1016\/j.otc.2012.05.002_bib59","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/cncr.23714","volume":"113","author":"Nonzee","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.otc.2012.05.002_bib60","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1524-4733.2007.00187.x","article-title":"Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices\u2014budget impact analysis","volume":"10","author":"Mauskopf","year":"2007","journal-title":"Value Health"},{"issue":"32","key":"10.1016\/j.otc.2012.05.002_bib61","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2011.05.018","article-title":"Economic burden of HPV-related cancers in France","volume":"29","author":"Borget","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.otc.2012.05.002_bib62","doi-asserted-by":"crossref","unstructured":"Remy V, Heitland W, Klussmann J, et\u00a0al. Economic burden of HPV-related head & neck cancer and anal cancers in Germany. Presentation at ISPOR 14th Annual European Congress, Madrid (Spain). November 5\u20138, 2011.","DOI":"10.1016\/j.jval.2011.08.1154"},{"issue":"Suppl 1","key":"10.1016\/j.otc.2012.05.002_bib63","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1111\/j.1524-4733.2008.00371.x","article-title":"A\u00a0study on indirect and intangible costs for patients with knee osteoarthritis in Singapore","volume":"11","author":"Xie","year":"2008","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.otc.2012.05.002_bib64","first-page":"505","article-title":"A\u00a0multicenter cost-of-illness study on rheumatoid arthritis in Italy","volume":"20","author":"Leardini","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib65","first-page":"443","article-title":"Valuing a hypothetical cure for rheumatoid arthritis using the contingent valuation methodology: the patient perspective","volume":"32","author":"Fautrel","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.otc.2012.05.002_bib66","unstructured":"Cancer trends progress report - costs of cancer care [Internet]. Available at: http:\/\/progressreport.cancer.gov\/doc_detail.asp?pid=1&did=2009&chid=95&coid=926&mid=. Accessed December 7, 2011."},{"key":"10.1016\/j.otc.2012.05.002_bib67","unstructured":"CDC - number of HPV-associated cancer cases per year [Internet]. Available at: http:\/\/www.cdc.gov.ezproxy.welch.jhmi.edu\/cancer\/hpv\/statistics\/cases.htm. Accessed December 8, 2011."},{"issue":"5","key":"10.1016\/j.otc.2012.05.002_bib68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"24","key":"10.1016\/j.otc.2012.05.002_bib69","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/jnci\/djn384","article-title":"Productivity costs of cancer mortality in the United States: 2000-2020","volume":"100","author":"Bradley","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"16","key":"10.1016\/j.otc.2012.05.002_bib70","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.276.16.1339","article-title":"Recommendations for reporting cost-effectiveness analyses. Panel on cost-effectiveness in health and medicine","volume":"276","author":"Siegel","year":"1996","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.otc.2012.05.002_bib71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1524-4733.2009.00660.x","article-title":"Good research practices for measuring drug costs in cost-effectiveness analyses: a societal perspective: the ISPOR Drug Cost Task Force report\u2013part II","volume":"13","author":"Garrison","year":"2010","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib72","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/11530650-000000000-00000","article-title":"Healthcare rationing by proxy: cost-effectiveness analysis and the misuse of the $50,000 threshold in the US","volume":"28","author":"Bridges","year":"2010","journal-title":"Pharmacoeconomics"},{"issue":"4","key":"10.1016\/j.otc.2012.05.002_bib73","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1177\/0272989X10371134","article-title":"Does Medicare have an implicit cost-effectiveness threshold?","volume":"30","author":"Chambers","year":"2010","journal-title":"Med Decis Making"},{"issue":"16","key":"10.1016\/j.otc.2012.05.002_bib74","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMp1007168","article-title":"Legislating against use of cost-effectiveness information","volume":"363","author":"Neumann","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.otc.2012.05.002_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.radonc.2005.09.007","article-title":"Cancer in the oropharynx: cost calculation of different treatment modalities for controlled primaries, relapses and grade III\/IV complications","volume":"77","author":"Nijdam","year":"2005","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.otc.2012.05.002_bib76","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/annonc\/mdr124","article-title":"Oropharyngeal cancer: clinical implications of the HPV connection","volume":"22","author":"Psyrri","year":"2011","journal-title":"Ann Oncol"},{"issue":"19","key":"10.1016\/j.otc.2012.05.002_bib77","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D\u2019Souza","year":"2007","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.otc.2012.05.002_bib78","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJMe1003607","article-title":"Prognostic implications of HPV in oropharyngeal cancer","volume":"363","author":"Lowy","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.otc.2012.05.002_bib79","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/lary.21412","article-title":"The cost-effectiveness of community-based screening for oral cancer in high-risk males in the United States: a Markov decision analysis approach","volume":"121","author":"Dedhia","year":"2011","journal-title":"Laryngoscope"},{"issue":"9","key":"10.1016\/j.otc.2012.05.002_bib80","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1158\/1940-6207.CAPR-11-0373","article-title":"Brush-based cytology screening in the tonsils and cervix: there is a difference!","volume":"4","author":"Lingen","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"10.1016\/j.otc.2012.05.002_bib81","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1158\/1940-6207.CAPR-11-0284","article-title":"Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal \u201cpap-test equivalent\u201d in high-risk populations","volume":"4","author":"Fakhry","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"10.1016\/j.otc.2012.05.002_bib82","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1158\/1940-6207.CAPR-11-0379","article-title":"HPV-associated oropharyngeal cancers\u2014are they preventable?","volume":"4","author":"Kreimer","year":"2011","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib83","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1071\/SH10018","article-title":"A\u00a0brief history of economic evaluation for human papillomavirus vaccination policy","volume":"7","author":"Beutels","year":"2010","journal-title":"Sex Health"},{"issue":"12","key":"10.1016\/j.otc.2012.05.002_bib84","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S1473-3099(10)70219-X","article-title":"Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis","volume":"10","author":"Kim","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib85","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ejca.2010.09.030","article-title":"Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?","volume":"47","author":"de Kok","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.otc.2012.05.002_bib86","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1758-3284-2-15","article-title":"Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)","volume":"2","author":"Dayyani","year":"2010","journal-title":"Head Neck Oncol"},{"issue":"19","key":"10.1016\/j.otc.2012.05.002_bib87","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1056\/NEJMp1110539","article-title":"The role of cost-effectiveness in U.S. vaccination policy","volume":"365","author":"Kim","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.otc.2012.05.002_bib88","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMsa0707052","article-title":"Health and economic implications of HPV vaccination in the United States","volume":"359","author":"Kim","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl Web Exclusives","key":"10.1016\/j.otc.2012.05.002_bib89","article-title":"National medical spending attributable to overweight and obesity: how much, and who\u2019s paying?","author":"Finkelstein","year":"2003","journal-title":"Health Aff (Millwood)"},{"issue":"3","key":"10.1016\/j.otc.2012.05.002_bib90","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/diacare.26.3.917","article-title":"Economic costs of diabetes in the US in 2002","volume":"26","author":"Hogan","year":"2003","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.otc.2012.05.002_bib91","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaci.2010.10.042","article-title":"The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel survey","volume":"127","author":"Sullivan","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.otc.2012.05.002_bib92","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/JOM.0b013e3181f475b2","article-title":"Economic burden of dermatitis in US workers","volume":"52","author":"Blanciforti","year":"2010","journal-title":"J\u00a0Occup Environ Med"},{"issue":"24","key":"10.1016\/j.otc.2012.05.002_bib93","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1093\/jnci\/djn434","article-title":"How should we value lives lost to cancer?","volume":"100","author":"Ramsey","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"}],"container-title":["Otolaryngologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666512000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0030666512000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T17:14:16Z","timestamp":1561914856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0030666512000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0030666512000667"],"URL":"https:\/\/doi.org\/10.1016\/j.otc.2012.05.002","relation":{},"ISSN":["0030-6665"],"issn-type":[{"value":"0030-6665","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}